867 — China Medical System Holdings Share News
0.000.00%
- HK$24.82bn
- HK$19.26bn
- CNY8.21bn
Brief: China Medical System Holdings Declared Interim Dividend
Brief: China Medical System Says Tablets Granted Approval For Drug Clinical Trial By NMPA
Brief: China Medical System Will Actively Move Forward Tildrakizumab Solution For Injection's New Drug Application In China
Brief: China Medical System Says New Drug Application Of Diazepam Nasal Spray Accepted By Nmpa
Brief: China Medical System Says Unit Entered Into A Strategic Collaboration Memorandum With Ec Healthcare
Brief: China Medical System Announces Equity Transfer & Capital Increase Agreements
Brief: China Medical System Announces Agreements For Strategic Collaboration With Trinomab Biotech
Brief: China Medical System Holdings Posts FY Turnover Of RMB6,946.0 Mln
Brief: China Medical System Holdings' Unit Buys All Issued & Outstanding Shares Of Luqa Ventures Co
Brief: China Medical System Says Desidustat Tablets Got Approval For Drug Clinical Trial From Nmpa
Swiss stocks - Factors to watch on December 4
Brief: China Medical System Says Via Unit Signed License, Collaboration & Distribution Agreement With Cosmo Technologies
Brief: China Medical System Says Group Through Unit Signs Distribution, Supply & License Deal
Brief: China Medical System Says 'Tildrakizumab' Granted Approval For Drug Clinical Trial
Brief: China Medical System Holdings Posts HY Turnover Up 4.8% To RMB3,108.1 MLN
Brief: China Medical System Says Cyclosporine Granted A Clinical Trial Notice Issued By NMPA
Brief: Gelesis Announces Partnership For Commercial Launch Of Plenity In China
Brief: Midatech Pharma Announces Amendment to Relationship Agreement
Brief: China Medical System Holdings Posts Profit For Year Attributable Of RMB1.96 Bln